3 May 2013
In - Research

The Fred Hutchinson Cancer Research Center in Seattle has released new research which explores whether taking cholesterol-lowering drugs may also reduce the risk of dying from prostate cancer.

Commenting on the research Dr Iain Frame, Director of Research at Prostate Cancer UK said: "Although several recent studies have explored whether taking statins regularly can reduce the risk of dying from prostate cancer, the results of this study still do not provide enough evidence to support this. These results are based on men already taking statins at the time their prostate cancer was diagnosed and we would not advise that any man with the disease start taking statins on the basis of this research. However we do suggest that anyone with concerns about the disease should discuss them with their GP."

comments powered by Disqus